1. Pink Sheet
  2. >>Geography
  3. >>International

WHO Lists Scientific & Ethical Features That All Good Clinical Trials Should Include

 
• By Vibha Sharma

In response to a World Health Assembly resolution on strengthening the global clinical trial ecosystem, the World Health Organization has drawn up a new draft guideline on best practices for clinical trials updating and adapting its previous work on research capacity.

Crowd of young and elderly men and women in trendy hipster clothes. Diverse group of stylish people standing together. Society or population, social diversity. Flat cartoon vector illustration.
WHO says it is vital to ensure that clinical trials include a diverse range of participants • Source: Shutterstock

The World Health Organization is inviting stakeholder feedback on a new draft guideline on best practices for clinical trials that aims to improve efficiency and minimize research waste, both in normal times and during an emergency or pandemics. 

The draft guideline includes recommendations on key scientific and ethical features that should be universal to all trials, irrespective of whether they are set in high- or low- and middle-income countries, to

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from International

Global Pharma Guidance Tracker - April 2025

 
• By Vibha Sharma and Anabel Costa-Ferreira

Stay up to date on regulatory guidelines from around the world with the Pink Sheet’s Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Quotable: Top Experts On Policy Hot Topics

 
• By Anabel Costa-Ferreira

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.

Companies Advised To Assess Potential Impacts Of Landmark Global Pandemic Treaty

 
• By Neena Brizmohun

Mechanisms in the draft treaty that the more than 190 member states of the World Health Organization have finally agreed to are expected to “materially affect companies,” particularly those that develop, manufacture or distribute pandemic-related health care products.

ICH Modernizes Stability Testing Guideline

 
• By Vibha Sharma

The International Council for Harmonisation has consolidated and modernized its existing stability guidelines into one document, and addressed modern stability testing approaches like modeling, bracketing, and matrixing.

More from Geography

Spain Slashes Wait Between EU Drug Authorization And Financing Decisions

 
• By Francesca Bruce

Spanish authorities say that that timelines for drug reimbursement decisions can be improved further with the right submissions from companies.

Spain Beats England To Tevimbra Reimbursement Recommendations

 
• By Francesca Bruce

Spanish authorities have published more pricing and reimbursement reports as part of a new drive to increase transparency.

Commission Taking ‘Due Account’ Of Scathing Report On EU Clinical Trial Bottlenecks

 
• By Vibha Sharma

A report by the European pharmaceutical industry criticizes the EU’s clinical trials framework, highlighting regulatory fragmentation, inefficiencies and the need for targeted reforms.